BIOIDENTICAL HORMONES MARKET SIZE TO 2026: SOTTOPELLE, NOVARTIS AG, ORION PHARMA AB, FULL LIFE WELLNESS CENTER

Global bioidentical hormones market is expected to rise to an estimated value of USD 508.41million by 2026 registering a substantial CAGR of 5.61% in the forecast period of 2019-2026. This rise in the market can be attributed to the easy availability of medicines and higher affordability capacity of people. Global Bioidentical Hormones Market By Types (Estrogens, Progesterone, Testosterone, Others), Product Types (Tablets & Capsules, Creams & Gels, Injectable, Patches & Implants, Others), End Users (Hospital, Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Get a Sample Report Now @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bioidentical-hormones-market

Few of the major market competitors currently working in the global bioidentical hormones  market are SottoPelle, Novartis AG,  Orion Pharma AB, Full Life Wellness Center, Advantage Pharmaceuticals, BioTE Medical, Merck KGaA, Pfizer Inc, TherapeuticsMD, Inc., GeneScience Pharmaceuticals Co., Ltd., SUPREMA., INMODE, United Pharmacy, LLC., Noven Pharmaceuticals, Inc., Novo Nordisk India Pvt Ltd, Defy Medical and others

Market Definition: 

Bioidentical hormones are identical to endogenous hormones on a molecular level and are used in hormone replacement therapy. These hormones have ability to reduce fatigue, hair thinning, can improve sleep and can increase sex drive. Few specific hormones used in bioidentical hormone replacement therapy include estrone, estradiol, progesterone, testosterone, dehydroepiandrosterone and estriol.

Market Drivers

Increasing geriatric population is driving the market for bioidentical hormones
Growing screening for hormonal deficiency is driving market
Rising awareness among consumers about bioidentical hormones is also acting as driving force
Rising income level of women are factors leading the market expansion

Market Restraints

It may lead to weight loss and Blurred vision
Increasing risk of heart attack and breast cancer will also hinder the market growth.

Table of Contents:

Introduction
Market Segmentation
Market Overview
Executive Summary
Premium Insights
Global, By Component
Product Type
Delivery
Industry Type
Geography

10.1.    Overview

10.2.    North America

10.3.    Europe

10.4.    Asia-Pacific

10.5.    South America

10.6.    Middle East & Africa

Company Landscape
Company Profiles
Related Reports

Download Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-bioidentical-hormones-market

Segmentation: 

By Types

Estrogens
Progesterone
Testosterone
others

By Product Types

Tablets & Capsules
Creams & Gels
Injectable
Patches & Implants

By End Users

Hospital
Clinics
Others

By Geography

North America
South America
Europe
Asia-Pacific
Middle East and Africa

Key Developments in the Market:

In October 2018, TherapeuticsMD, Inc., announced the launch of their bioidentical hormone combo Bijuva which is the first bioidentical combo hormone therapy drug that is approved by  The main aim of the launch is to reach some 3,000 high-volume compounding pharmacies to garner their interest in replacing their compounded bioidentical estradiol and progesterone with Bijuva. Bijuva offers bio-identical estradiol to reduce moderate to severe hot flashes combined with bio-identical progesterone to reduce risks to the endometrium.
In December 2018, Pellecome announced the launch of their new treatment for weight loss to be used with its advanced pellet delivery system, similar to the bioidentical hormone replacement therapy. These pellets are inserted under the skin and absorbs by the body over a period of time. This new advanced therapy is easier, safer, reliable and convenient way of treatment for patients

Competitive Analysis: Global Bioidentical Hormones Market

Global bioidentical hormones market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of bioidentical hormones market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global bioidentical hormones devices market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Order a Copy of This Research Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-bioidentical-hormones-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster eSfficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.